Cargando…

The role of novel programmed cell death in head and neck squamous cell carcinoma: from mechanisms to potential therapies

Head and neck squamous cell carcinoma (HNSCC) is a common oral cancer with poor prognosis and for which no targeted therapeutic strategies are currently available. Accumulating evidence has demonstrated that programmed cell death (PCD) is essential in the development of HNSCC as a second messenger....

Descripción completa

Detalles Bibliográficos
Autores principales:	Xi, Yujie, Gao, Ling, Li, Shaming, Sun, Kai, Chen, Peishen, Cai, Zhen, Ren, Wenhao, Zhi, Keqian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560744/ https://www.ncbi.nlm.nih.gov/pubmed/37818196 http://dx.doi.org/10.3389/fphar.2023.1228985

Ejemplares similares

Promising Druggable Target in Head and Neck Squamous Cell Carcinoma: Wnt Signaling
por: Aminuddin, Amnani, et al.
Publicado: (2016)

Roles of Major RNA Adenosine Modifications in Head and Neck Squamous Cell Carcinoma
por: Huo, Xing-xing, et al.
Publicado: (2021)

The Molecular Basis and Therapeutic Aspects of Cisplatin Resistance in Oral Squamous Cell Carcinoma
por: Cheng, Yali, et al.
Publicado: (2021)

Amphipathic barbiturates as marine product mimics with cytolytic and immunogenic effects on head and neck squamous cell carcinoma cell lines
por: von Hofsten, Susannah, et al.
Publicado: (2023)

Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Pan, Yunbao, et al.
Publicado: (2019)

Identification of lncRNA Signature of Tumor-Infiltrating T Lymphocytes With Potential Implications for Prognosis and Chemotherapy of Head and Neck Squamous Cell Carcinoma
por: Wang, Liping, et al.
Publicado: (2022)

A novel necroptosis-related LncRNA signature for prediction of prognosis and therapeutic responses of head and neck squamous cell carcinoma
por: Meng, Zilu, et al.
Publicado: (2022)

Pharmacological impact of microRNAs in head and neck squamous cell carcinoma: Prevailing insights on molecular pathways, diagnosis, and nanomedicine treatment
por: Bhattacharjee, Bedanta, et al.
Publicado: (2023)

Locally advanced head and neck squamous cell carcinoma treatment efficacy and safety: a systematic review and network meta-analysis
por: Wang, Huanhuan, et al.
Publicado: (2023)

A Novel Hydroxamate-Based Compound WMJ-J-09 Causes Head and Neck Squamous Cell Carcinoma Cell Death via LKB1-AMPK-p38MAPK-p63-Survivin Cascade
por: Yen, Chia-Sheng, et al.
Publicado: (2018)

Diagnostic Value of CircRNAs as Potential Biomarkers in Oral Squamous Cell Carcinoma: a Meta-Analysis
por: Wang, Mingfei, et al.
Publicado: (2021)

Circ-PKD2 promotes Atg13-mediated autophagy by inhibiting miR-646 to increase the sensitivity of cisplatin in oral squamous cell carcinomas
por: Gao, Ling, et al.
Publicado: (2022)

Immunocompromised and immunocompetent mouse models for head and neck squamous cell carcinoma
por: Lei, Zhen-ge, et al.
Publicado: (2016)

Niclosamide Induces Cell Cycle Arrest in G1 Phase in Head and Neck Squamous Cell Carcinoma Through Let-7d/CDC34 Axis
por: Han, Zewen, et al.
Publicado: (2019)

The microRNA-10b-Bim axis promotes cancer progression through activating autophagy in oral squamous cell carcinoma
por: Li, Shaoming, et al.
Publicado: (2022)

Evaluation of Programmed Death - Ligand 1 (Pd-L1) Expression in Head and Neck Squamous Cell Carcinoma
por: Unnikrishnan, Aarya, et al.
Publicado: (2023)

Editorial: Liver diseases and programmed cell death
por: Cao, Peng, et al.
Publicado: (2023)

Effect of regulatory cell death on the occurrence and development of head and neck squamous cell carcinoma
por: Xue, Yuting, et al.
Publicado: (2023)

Surgical management of Squamous Cell Carcinoma of the lower lip: An experience of 109 cases
por: Rena, Wenhao, et al.
Publicado: (2014)

Programmed Cell Death-Ligand 1 in Head and Neck Squamous Cell Carcinoma: Molecular Insights, Preclinical and Clinical Data, and Therapies
por: Meliante, Piero Giuseppe, et al.
Publicado: (2022)

Changes in programmed death-ligand 1 expression during cisplatin treatment in patients with head and neck squamous cell carcinoma
por: Ock, Chan-Young, et al.
Publicado: (2017)

The RBP1–CKAP4 axis activates oncogenic autophagy and promotes cancer progression in oral squamous cell carcinoma
por: Gao, Ling, et al.
Publicado: (2020)

Fitter Mitochondria Are Associated With Radioresistance in Human Head and Neck SQD9 Cancer Cells
por: Grasso, Debora, et al.
Publicado: (2020)

The prospects and challenges of chimeric antigen receptor T cell therapy for head and neck squamous cell carcinoma
por: Liu, Wei, et al.
Publicado: (2023)

An Immunogenic Cell Death-Related Classification Predicts Prognosis and Response to Immunotherapy in Head and Neck Squamous Cell Carcinoma
por: Wang, Xinwen, et al.
Publicado: (2021)

Programmed Cell Death Protein 1/Programmed Cell Death Protein Ligand 1 Immunosuppressants in Advanced Non-Small Cell Lung Cancer Research Progress in Treatment
por: Li, Feng, et al.
Publicado: (2022)

Positive clinical outcomes following therapy with programmed cell death protein 1/programmed cell death ligand 1 inhibitors in neuroendocrine carcinoma of the cervix
por: Liu, Rongyu, et al.
Publicado: (2022)

Head and neck squamous cell carcinoma-specific prognostic signature and drug sensitive subtypes based on programmed cell death-related genes
por: Xu, Chengbo, et al.
Publicado: (2023)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

PKHB1 peptide induces antiviral effects through induction of immunogenic cell death in herpes simplex keratitis
por: He, Yun, et al.
Publicado: (2022)

Single-cell genomic analysis of head and neck squamous cell carcinoma
por: Stucky, Andres, et al.
Publicado: (2017)

Therapeutic Targeting of MYC in Head and Neck Squamous Cell Carcinoma
por: Liu, Shuo, et al.
Publicado: (2022)

Nimotuzumab Induces NK Cell Activation, Cytotoxicity, Dendritic Cell Maturation and Expansion of EGFR-Specific T Cells in Head and Neck Cancer Patients
por: Mazorra, Zaima, et al.
Publicado: (2017)

Cutaneous Squamous Cell Carcinoma of the Head and Neck
por: Gurudutt, Vivek V., et al.
Publicado: (2011)

Hypoxia in Head and Neck Squamous Cell Carcinoma
por: Li, John Zenghong, et al.
Publicado: (2012)

Immunotherapy for head and neck squamous cell carcinoma
por: Fuereder, Thorsten
Publicado: (2016)

Immunotherapy for Head and Neck Squamous Cell Carcinoma
por: Moskovitz, Jessica, et al.
Publicado: (2018)

Immunotherapy in Head and Neck Squamous Cell Cancer
por: Denaro, Nerina, et al.
Publicado: (2018)

Exosomes in Head and Neck Squamous Cell Carcinoma
por: Xiao, Cheng, et al.
Publicado: (2019)

Dual induction of apoptotic and autophagic cell death by targeting survivin in head neck squamous cell carcinoma
por: Zhang, L, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4c2cmojeob501mmuljdsdutov6